Please assess the completion status of the following clinical trial:

Trial Title: Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* diagnosis of Hodgkin lymphoma~* FSH and LH levels in peripheral blood below 15 IU/l~* fertile age from 18 to 35 years~* female~* presence of both ovaries~Exclusion Criteria:~* ovarian tumours or cysts over 40 mm in diameter

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 35 Years
- Healthy Volunteers: f

Study Arms:
- case group (Type: EXPERIMENTAL): Throughout the course of chemotherapy, patients were administered triptorelin (Diphereline SR 3 mg, Ibsen) in the form of i.m. injections, always once a month and simultaneously with the chemotherapy.
- control group (Type: NO_INTERVENTION): no intervention

Based on this trial design, predict the completion outcome and termination type (if applicable).